Why Talis Biomedical (TLIS) Stock Is Exploding Higher
Why Talis Biomedical (TLIS) Stock Is Exploding Higher
Talis Biomedical Corp (NASDAQ:TLIS) shares are trading higher by 30% to $7.03 Tuesday morning after the company announced it is exploring strategic options to boost shareholder value due to current market conditions.
塔利斯生物醫學公司 納斯達克股票代碼：TLIS）週二上午股價上漲30％，至7.03美元，此前該公司宣佈，由於當前的市場狀況，正在探索戰略選擇以提高股東價值。
What Happened?
發生了什麼？
Talis Biomedical formed a special committee to consider various alternatives like financing, mergers or asset divestiture. To cut costs, the company is reducing its workforce by 90% and consolidating operations in Chicago.
Talis Biomedical成立了一個特別委員會，負責考慮融資、兼併或資產剝離等各種替代方案。爲了削減成本，該公司正在裁員90％，並整合在芝加哥的業務。
Despite this, revenue decreased significantly in third-quarter 2023 compared to the same period last year, but operating expenses and net losses have also decreased. They've disclosed cash reserves of $88.0 million as of September 30.
儘管如此，2023年第三季度的收入與去年同期相比大幅下降，但運營費用和淨虧損也有所下降。他們披露截至9月30日的現金儲備爲8,800萬美元。
As they evaluate options, Talis Biomedical won't hold a conference call to discuss their third-quarter results. Further details can be found in their Quarterly Report on Form 10-Q for third-quarter, 2023.
在評估選項時，Talis Biomedical不會舉行電話會議來討論其第三季度的業績。更多詳細信息可以在他們的2023年第三季度10-Q表季度報告中找到。
See Also: Fisker Stock Is Tumbling Tuesday: What's Going On?
另見：週二菲斯克股票暴跌：發生了什麼？
According to data from Benzinga Pro, TLIS has a 52-week high of $9.75 and a 52-week low of $4.35.
根據Benzinga Pro的數據，TLIS的52周高點爲9.75美元，52周低點爲4.35美元。
譯文內容由第三人軟體翻譯。